{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T03:26:54Z","timestamp":1785036414228,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and objective<\/jats:title>\n                <jats:p>There is currently no FDA-approved medical therapy for delayed graft function (DGF). Dexmedetomidine (DEX) has multiple reno-protective effects preventing ischemic reperfusion injury, DGF, and acute kidney injury. Therefore, we aimed to evaluate the reno-protective effects of perioperative DEX during renal transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic review and meta-analysis synthesizing randomized controlled trials (RCTs) from WOS, SCOPUS, EMBASE, PubMed, and CENTRAL until June 8th, 2022. We used the risk ratio (RR) for dichotomous outcomes and the mean difference for continuous outcomes; both presented with the corresponding 95% confidence interval (CI). We registered our protocol in PROSPERO with ID: CRD42022338898.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We included four RCTs with 339 patients. Pooled risk ratio found no difference between DEX and placebo in reducing DGF (RR: 0.58 with 95% CI [0.34, 1.01], p\u2009=\u20090.05) and acute rejection (RR: 0.88 with 95% CI [0.52, 1.49], p\u2009=\u20090.63). However, DEX improved short-term creatinine on day 1 (MD: \u2212\u00a00.76 with 95% CI [\u2212\u00a01.23, \u2212\u00a00.3], p\u2009=\u20090.001) and day 2 (MD: \u2212\u00a00.28 with 95% CI [\u2212\u00a00.5, \u2212\u00a00.07], p\u2009=\u20090.01); and blood urea nitrogen on day 2 (MD: \u2212\u00a010.16 with 95% CI [\u2212\u00a017.21, \u2212\u00a03.10], p\u2009=\u20090.005) and day 3 (MD: \u2212\u00a06.72 with 95% CI [\u2212\u00a012.85, \u2212\u00a00.58], p\u2009=\u20090.03).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Although there is no difference between DEX and placebo regarding reducing DGF and acute rejection after kidney transplantation, there may be some evidence that it has reno-protective benefits because we found statistically significant improvement in the short-term serum creatinine and blood urea nitrogen levels. More trials are required to investigate the long-term reno-protective effects of DEX.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11255-023-03568-3","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T11:23:14Z","timestamp":1680607394000},"page":"2545-2556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Reno-protective effects of perioperative dexmedetomidine in kidney transplantation: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"55","author":[{"given":"Mohamed T.","family":"Abuelazm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Johanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2056-1361","authenticated-orcid":false,"given":"Abdul Rhman","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basant E.","family":"Katamesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa Atef","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Abdelazeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"3568_CR1","unstructured":"Annual Data Report|USRDS. https:\/\/adr.usrds.org\/2021\/end-stage-renal-disease\/1-incidence-prevalence-patient-characteristics-and-treatment-modalities"},{"key":"3568_CR2","unstructured":"(2021) Annual Data Report|USRDS. https:\/\/adr.usrds.org\/2021\/end-stage-renal-disease\/7-transplantation. Accessed 20 Aug 2022"},{"key":"3568_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.kint.2018.10.009","volume":"95","author":"SF Smith","year":"2019","unstructured":"Smith SF, Hosgood SA, Nicholson ML (2019) Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells. Kidney Int 95:50\u201356. https:\/\/doi.org\/10.1016\/j.kint.2018.10.009","journal-title":"Kidney Int"},{"key":"3568_CR4","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/ndt\/gft488","volume":"29","author":"C Ponticelli","year":"2014","unstructured":"Ponticelli C (2014) Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. Nephrol Dial Transpl 29:1134\u20131140. https:\/\/doi.org\/10.1093\/ndt\/gft488","journal-title":"Nephrol Dial Transpl"},{"key":"3568_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0885066607309998","volume":"23","author":"MH Rosner","year":"2008","unstructured":"Rosner MH, Portilla D, Okusa MD (2008) Analytic reviews: cardiac surgery as a cause of acute kidney injury: pathogenesis and potential therapies. J Intensive Care Med 23:3\u201318. https:\/\/doi.org\/10.1177\/0885066607309998","journal-title":"J Intensive Care Med"},{"key":"3568_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s12882-020-02181-1","volume":"21","author":"R Chen","year":"2020","unstructured":"Chen R, Wang H, Song L et al (2020) Predictors and one-year outcomes of patients with delayed graft function after deceased donor kidney transplantation. BMC Nephrol 21:526. https:\/\/doi.org\/10.1186\/s12882-020-02181-1","journal-title":"BMC Nephrol"},{"key":"3568_CR7","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/S0140-6736(04)17406-0","volume":"364","author":"N Perico","year":"2004","unstructured":"Perico N, Cattaneo D, Sayegh MH, Remuzzi G (2004) Delayed graft function in kidney transplantation. Lancet 364:1814\u20131827. https:\/\/doi.org\/10.1016\/S0140-6736(04)17406-0","journal-title":"Lancet"},{"key":"3568_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/ki.2015.190","volume":"88","author":"WK Wu","year":"2015","unstructured":"Wu WK, Famure O, Li Y, Kim SJ (2015) Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation. Kidney Int 88:851\u2013858. https:\/\/doi.org\/10.1038\/ki.2015.190","journal-title":"Kidney Int"},{"key":"3568_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00330","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, He J, Yu N et al (2020) Mechanisms of dexmedetomidine in neuropathic pain. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00330","journal-title":"Front Neurosci"},{"key":"3568_CR10","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1345\/aph.1M310","volume":"43","author":"AT Gerlach","year":"2009","unstructured":"Gerlach AT, Murphy CV, Dasta JF (2009) An updated focused review of dexmedetomidine in adults. Ann Pharmacother 43:2064\u20132074. https:\/\/doi.org\/10.1345\/aph.1M310","journal-title":"Ann Pharmacother"},{"key":"3568_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/08998280.2021.1997063","volume":"35","author":"B Abdelazeem","year":"2021","unstructured":"Abdelazeem B, Malik B, Mohamed MMG et al (2021) Meta-analysis comparing dexmedetomidine versus standard of care for sedation in patients with sepsis. Proc (Bayl Univ Med Cent) 35:184\u2013189. https:\/\/doi.org\/10.1080\/08998280.2021.1997063","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"3568_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3892\/br.2015.427","volume":"3","author":"F Tan","year":"2015","unstructured":"Tan F, Chen Y, Yuan D et al (2015) Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats. Biomed Rep 3:365\u2013370. https:\/\/doi.org\/10.3892\/br.2015.427","journal-title":"Biomed Rep"},{"key":"3568_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.bja.2019.07.027","volume":"123","author":"K Wang","year":"2019","unstructured":"Wang K, Wu M, Xu J et al (2019) Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis. Br J Anaesth 123:777\u2013794. https:\/\/doi.org\/10.1016\/j.bja.2019.07.027","journal-title":"Br J Anaesth"},{"key":"3568_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00790","author":"T Yang","year":"2020","unstructured":"Yang T, Feng X, Zhao Y et al (2020) Dexmedetomidine enhances autophagy via \u03b12-AR\/AMPK\/mTOR pathway to inhibit the activation of NLRP3 inflammasome and subsequently alleviates lipopolysaccharide-induced acute kidney injury. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.00790","journal-title":"Front Pharmacol"},{"key":"3568_CR15","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.bbrc.2017.12.090","volume":"495","author":"Y Li","year":"2018","unstructured":"Li Y, Pan Y, Gao L et al (2018) Dexmedetomidine attenuates pancreatic injury and inflammatory response in mice with pancreatitis by possible reduction of NLRP3 activation and up-regulation of NET expression. Biochem Biophys Res Commun 495:2439\u20132447. https:\/\/doi.org\/10.1016\/j.bbrc.2017.12.090","journal-title":"Biochem Biophys Res Commun"},{"key":"3568_CR16","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3892\/mmr.2014.2034","volume":"9","author":"Y Cai","year":"2014","unstructured":"Cai Y, Xu H, Yan J et al (2014) Molecular targets and mechanism of action of dexmedetomidine in treatment of ischemia\/reperfusion injury. Mol Med Rep 9:1542\u20131550. https:\/\/doi.org\/10.3892\/mmr.2014.2034","journal-title":"Mol Med Rep"},{"key":"3568_CR17","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1186\/cc10283","volume":"15","author":"J Gu","year":"2011","unstructured":"Gu J, Sun P, Zhao H et al (2011) Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care 15:R153. https:\/\/doi.org\/10.1186\/cc10283","journal-title":"Crit Care"},{"key":"3568_CR18","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1213\/ANE.0000000000003820","volume":"130","author":"J Ma","year":"2020","unstructured":"Ma J, Chen Q, Li J et al (2020) Dexmedetomidine-mediated prevention of renal ischemia-reperfusion injury depends in part on cholinergic anti-inflammatory mechanisms. Anesth Analg 130:1054","journal-title":"Anesth Analg"},{"key":"3568_CR19","doi-asserted-by":"publisher","first-page":"118004","DOI":"10.1016\/j.lfs.2020.118004","volume":"257","author":"C Tang","year":"2020","unstructured":"Tang C, Hu Y, Gao J et al (2020) Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat. Life Sci 257:118004. https:\/\/doi.org\/10.1016\/j.lfs.2020.118004","journal-title":"Life Sci"},{"key":"3568_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bja.2019.12.036","volume":"124","author":"S Soh","year":"2020","unstructured":"Soh S, Shim J-K, Song J-W et al (2020) Effect of dexmedetomidine on acute kidney injury after aortic surgery: a single-centre, placebo-controlled, randomised controlled trial. Br J Anaesth 124:386\u2013394. https:\/\/doi.org\/10.1016\/j.bja.2019.12.036","journal-title":"Br J Anaesth"},{"key":"3568_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/PCC.0000000000000611","volume":"17","author":"DM Kwiatkowski","year":"2016","unstructured":"Kwiatkowski DM, Axelrod DM, Sutherland SM et al (2016) Dexmedetomidine is associated with lower incidence of acute kidney injury after congenital heart surgery. Pediatr Crit Care Med 17:128\u2013134","journal-title":"Pediatr Crit Care Med"},{"key":"3568_CR22","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/cts.12826","volume":"13","author":"J Chen","year":"2020","unstructured":"Chen J, Perez R, de Mattos AM et al (2020) Perioperative dexmedetomidine improves outcomes of kidney transplant. Clin Transl Sci 13:1279\u20131287. https:\/\/doi.org\/10.1111\/cts.12826","journal-title":"Clin Transl Sci"},{"key":"3568_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4097\/kja.19259","volume":"72","author":"S Lee","year":"2019","unstructured":"Lee S (2019) Dexmedetomidine: present and future directions. Korean J Anesthesiol 72:323\u2013330. https:\/\/doi.org\/10.4097\/kja.19259","journal-title":"Korean J Anesthesiol"},{"key":"3568_CR24","doi-asserted-by":"publisher","first-page":"654381","DOI":"10.1155\/2012\/654381","volume":"2012","author":"ES Tripodaki","year":"2012","unstructured":"Tripodaki ES, Tasoulis A, Koliopoulou A et al (2012) Microcirculation and macrocirculation in cardiac surgical patients. Crit Care Res Pract 2012:654381. https:\/\/doi.org\/10.1155\/2012\/654381","journal-title":"Crit Care Res Pract"},{"key":"3568_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9275406","author":"Z Liu","year":"2022","unstructured":"Liu Z, Jin Y, Feng C et al (2022) Renoprotective effect of intraoperative dexmedetomidine in renal transplantation. Comput Math Methods Med. https:\/\/doi.org\/10.1155\/2022\/9275406","journal-title":"Comput Math Methods Med"},{"key":"3568_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12630-021-02173-1","volume":"69","author":"JH Park","year":"2022","unstructured":"Park JH, Koo BN, Kim MS et al (2022) Effects of intraoperative dexmedetomidine infusion on renal function in elective living donor kidney transplantation: a randomized controlled trial. Can J Anesth 69:448\u2013459. https:\/\/doi.org\/10.1007\/s12630-021-02173-1","journal-title":"Can J Anesth"},{"key":"3568_CR27","doi-asserted-by":"publisher","first-page":"e2215217","DOI":"10.1001\/jamanetworkopen.2022.15217","volume":"5","author":"X Shan","year":"2022","unstructured":"Shan X, Hu L, Wang Y et al (2022) Effect of perioperative dexmedetomidine on delayed graft function following a donation-after-cardiac-death kidney transplant. JAMA Netw Open 5:e2215217. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.15217","journal-title":"JAMA Netw Open"},{"key":"3568_CR28","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1080\/07853890.2022.2067351","volume":"54","author":"YC Wang","year":"2022","unstructured":"Wang YC, Wang MJ, Lee CY et al (2022) Effects of perioperative dexmedetomidine infusion on renal function and microcirculation in kidney transplant recipients: a randomised controlled trial. Ann Med 54:1233\u20131243. https:\/\/doi.org\/10.1080\/07853890.2022.2067351","journal-title":"Ann Med"},{"key":"3568_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.N71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/BMJ.N71","journal-title":"BMJ"},{"key":"3568_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","author":"JPT Higgins","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J et al (2019) Cochrane handbook for systematic reviews of interventions. Cochrane Handb Syst Rev Interv. https:\/\/doi.org\/10.1002\/9781119536604","journal-title":"Cochrane Handb Syst Rev Interv"},{"key":"3568_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2215\/CJN.13961119","volume":"15","author":"M Ann Lim","year":"2020","unstructured":"Ann Lim M, Bloom RD (2020) Medical therapies to reduce delayed graft function and improve long-term graft survival are we making progress? Clin J Am Soc Nephrol 15:13\u201315. https:\/\/doi.org\/10.2215\/CJN.13961119","journal-title":"Clin J Am Soc Nephrol"},{"key":"3568_CR32","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","volume":"9","author":"BL Kasiske","year":"2009","unstructured":"Kasiske BL, Zeier MG, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Chapman JR, Flavio GVSA (2009) KDIGO\u2014Kidney Disease Improving Global Outcomes: Transplant Work Group. Clinical Practice guideline for the care of Kidney transplant recipients. Am J Transpl 9:S1-155","journal-title":"Am J Transpl"},{"key":"3568_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.D5928","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. https:\/\/doi.org\/10.1136\/BMJ.D5928","journal-title":"BMJ"},{"key":"3568_CR34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/BMJ.39490.551019.BE","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Kunz R et al (2008) Rating quality of evidence and strength of recommendations: what is \u201cquality of evidence\u201d and why is it important to clinicians? BMJ Br Med J 336:995. https:\/\/doi.org\/10.1136\/BMJ.39490.551019.BE","journal-title":"BMJ Br Med J"},{"key":"3568_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/BMJ.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE et al (2008) Rating quality of evidence and strength of recommendations: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ Br Med J 336:924. https:\/\/doi.org\/10.1136\/BMJ.39489.470347.AD","journal-title":"BMJ Br Med J"},{"key":"3568_CR36","unstructured":"RevMan|Cochrane Training. https:\/\/training.cochrane.org\/online-learning\/core-software-cochrane-reviews\/revman. Accessed 3 Aug 2021"},{"key":"3568_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/BMJ.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634. https:\/\/doi.org\/10.1136\/BMJ.315.7109.629","journal-title":"BMJ"},{"key":"3568_CR38","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.transproceed.2021.05.008","volume":"53","author":"JE Lee","year":"2021","unstructured":"Lee JE, Jung H, Cho JD et al (2021) The role of dexmedetomidine in hepatic ischemia-reperfusion injury via a nitric oxide-dependent mechanism in rats. Transpl Proc 53:2060\u20132069. https:\/\/doi.org\/10.1016\/j.transproceed.2021.05.008","journal-title":"Transpl Proc"},{"key":"3568_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/ejn.12024","volume":"37","author":"M Fukuda","year":"2013","unstructured":"Fukuda M, Vazquez AL, Zong X, Kim SG (2013) Effects of the \u03b12-adrenergic receptor agonist dexmedetomidine on neural, vascular and BOLD fMRI responses in the somatosensory cortex. Eur J Neurosci 37:80\u201395. https:\/\/doi.org\/10.1111\/ejn.12024","journal-title":"Eur J Neurosci"},{"key":"3568_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/prp2.45","volume":"2","author":"J Lempi\u00e4inen","year":"2014","unstructured":"Lempi\u00e4inen J, Finckenberg P, Mervaala EE et al (2014) Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury. Pharmacol Res Perspect 2:3","journal-title":"Pharmacol Res Perspect"},{"key":"3568_CR41","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bja.2018.07.007","volume":"121","author":"Y Si","year":"2018","unstructured":"Si Y, Bao H, Han L et al (2018) Dexmedetomidine attenuation of renal ischaemia-reperfusion injury requires sirtuin 3 activation. Br J Anaesth 121:1260\u20131271. https:\/\/doi.org\/10.1016\/j.bja.2018.07.007","journal-title":"Br J Anaesth"},{"key":"3568_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/journal.pone.0077446","volume":"8","author":"F Ji","year":"2013","unstructured":"Ji F, Li Z, Ypoung JN et al (2013) Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass. PLoS ONE 8:10","journal-title":"PLoS ONE"},{"key":"3568_CR43","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1093\/ndt\/gfr023","volume":"26","author":"PC Xu","year":"2011","unstructured":"Xu PC, Zhang JJ, Chen M et al (2011) Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity. Nephrol Dial Transpl 26:3229\u20133236. https:\/\/doi.org\/10.1093\/ndt\/gfr023","journal-title":"Nephrol Dial Transpl"},{"key":"3568_CR44","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/01.tp.0000295982.78039.ef","volume":"84","author":"MM Van Timmeren","year":"2007","unstructured":"Van Timmeren MM, Vaidya VS, Van Ree RM et al (2007) High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 84:1625\u20131630. https:\/\/doi.org\/10.1097\/01.tp.0000295982.78039.ef","journal-title":"Transplantation"},{"key":"3568_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/ICVTS\/IVU367","volume":"20","author":"OO Balkanay","year":"2015","unstructured":"Balkanay OO, Goksedef D, Omeroglu SN, Ipek G (2015) The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interact Cardiovasc Thorac Surg 20:209\u2013214. https:\/\/doi.org\/10.1093\/ICVTS\/IVU367","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"3568_CR46","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/ki.2015.306","volume":"89","author":"JS Cho","year":"2016","unstructured":"Cho JS, Shim JK, Soh S et al (2016) Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int 89:693\u2013700. https:\/\/doi.org\/10.1038\/ki.2015.306","journal-title":"Kidney Int"},{"key":"3568_CR47","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/j.1600-6143.2011.03754.x","volume":"11","author":"A Siedlecki","year":"2011","unstructured":"Siedlecki A, Irish W, Brennan DC (2011) Delayed graft function in the kidney transplant. Am J Transpl 11:2279\u20132296. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03754.x","journal-title":"Am J Transpl"},{"key":"3568_CR48","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/ndt\/gfn667","volume":"24","author":"SG Yarlagadda","year":"2009","unstructured":"Yarlagadda SG, Coca SG, Formica RN et al (2009) Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transpl 24:1039\u20131047. https:\/\/doi.org\/10.1093\/ndt\/gfn667","journal-title":"Nephrol Dial Transpl"},{"key":"3568_CR49","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1016\/j.transproceed.2008.10.004","volume":"40","author":"M Kosieradzki","year":"2008","unstructured":"Kosieradzki M, Rowi\u0144ski W (2008) Ischemia\/reperfusion injury in kidney transplantation: mechanisms and prevention. Transpl Proc 40:3279\u20133288. https:\/\/doi.org\/10.1016\/j.transproceed.2008.10.004","journal-title":"Transpl Proc"},{"key":"3568_CR50","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s11255-013-0624-7","volume":"46","author":"V Lezaic","year":"2014","unstructured":"Lezaic V, Dajak M, Radivojevic D et al (2014) Cystatin C and serum creatinine as predictors of kidney graft outcome. Int Urol Nephrol 46:1447\u20131454. https:\/\/doi.org\/10.1007\/s11255-013-0624-7","journal-title":"Int Urol Nephrol"},{"key":"3568_CR51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.mcna.2016.01.002","volume":"100","author":"RJ Goldberg","year":"2016","unstructured":"Goldberg RJ, Weng FL, Kandula P (2016) Acute and chronic allograft dysfunction in kidney transplant recipients. Med Clin North Am 100:487\u2013503. https:\/\/doi.org\/10.1016\/j.mcna.2016.01.002","journal-title":"Med Clin North Am"},{"key":"3568_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s0734-3299(08)70353-8","volume":"2007","author":"R Nanda","year":"2007","unstructured":"Nanda R, Zanotti-Cavazzoni SL (2007) Early changes in organ function predict eventual survival in severe sepsis. Yearb Crit Care Med 2007:207\u2013209. https:\/\/doi.org\/10.1016\/s0734-3299(08)70353-8","journal-title":"Yearb Crit Care Med"},{"key":"3568_CR53","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/01.ASN.0000130340.93930.DD","volume":"15","author":"A Lassnigg","year":"2004","unstructured":"Lassnigg A, Schmidlin D, Mouhieddine M et al (2004) Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15:1597\u20131605","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3568_CR54","first-page":"90","volume":"22","author":"J Pascual","year":"2009","unstructured":"Pascual J, Marc\u00e9n R, Zamora J, \u00e9t al. (2009) Very early serum creatinine as a surrogate marker for graft survival beyond 10 years. J Nephrol 22(1):90\u201398","journal-title":"J Nephrol"},{"key":"3568_CR55","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.transproceed.2007.04.006","volume":"39","author":"HT Khosroshahi","year":"2007","unstructured":"Khosroshahi HT, Oskui R, Shoja MM et al (2007) Time-dependent variations in urine output after renal transplantation. Transpl Proc 39:932\u2013933. https:\/\/doi.org\/10.1016\/j.transproceed.2007.04.006","journal-title":"Transpl Proc"},{"key":"3568_CR56","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5527\/wjn.v4.i3.345","volume":"4","author":"J Santos","year":"2015","unstructured":"Santos J (2015) Estimating glomerular filtration rate in kidney transplantation: still searching for the best marker. World J Nephrol 4:345. https:\/\/doi.org\/10.5527\/wjn.v4.i3.345","journal-title":"World J Nephrol"},{"key":"3568_CR57","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1681\/ASN.2005050512","volume":"16","author":"C White","year":"2005","unstructured":"White C, Akbari A, Hussain N et al (2005) Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol 16:3763\u20133770. https:\/\/doi.org\/10.1681\/ASN.2005050512","journal-title":"J Am Soc Nephrol"},{"key":"3568_CR58","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/nejmoa1214234","volume":"369","author":"MG Shlipak","year":"2013","unstructured":"Shlipak MG, Matsushita K, \u00c4rnl\u00f6v J et al (2013) Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369:932\u2013943. https:\/\/doi.org\/10.1056\/nejmoa1214234","journal-title":"N Engl J Med"},{"key":"3568_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1306-1","author":"M Seki","year":"2019","unstructured":"Seki M, Nakayama M, Sakoh T et al (2019) Blood urea nitrogen is independently associated with renal outcomes in Japanese patients with stage 3\u20135 chronic kidney disease: a prospective observational study. BMC Nephrol. https:\/\/doi.org\/10.1186\/s12882-019-1306-1","journal-title":"BMC Nephrol"},{"key":"3568_CR60","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s11255-016-1276-1","volume":"48","author":"CG Musso","year":"2016","unstructured":"Musso CG, \u00c1lvarez-Gregori J, Jauregui J, Mac\u00edas-N\u00fa\u00f1ez JF (2016) Glomerular filtration rate equations: a comprehensive review. Int Urol Nephrol 48:1105\u20131110. https:\/\/doi.org\/10.1007\/s11255-016-1276-1","journal-title":"Int Urol Nephrol"},{"key":"3568_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.jvca.2015.03.025","volume":"30","author":"T Moon","year":"2016","unstructured":"Moon T, Tsai JY, Vachhani S et al (2016) The use of intraoperative dexmedetomidine is not associated with a reduction in acute kidney injury after lung cancer surgery. J Cardiothorac Vasc Anesth 30:51\u201355. https:\/\/doi.org\/10.1053\/j.jvca.2015.03.025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"3568_CR62","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1399-6576.2011.02427.x","volume":"55","author":"A Bayram","year":"2011","unstructured":"Bayram A, Esmaoglu A, Akin A et al (2011) The effects of intraoperative infusion of dexmedetomidine on early renal function after percutaneous nephrolithotomy. Acta Anaesthesiol Scand 55:539\u2013544. https:\/\/doi.org\/10.1111\/j.1399-6576.2011.02427.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"3568_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080825","author":"CF Lee","year":"2021","unstructured":"Lee CF, Cheng CH, Hung HC et al (2021) Sedative and immunosuppressive effects of dexmedetomidine in transplantation. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph14080825","journal-title":"Pharmaceuticals"},{"key":"3568_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0866-0","author":"JY Xu","year":"2015","unstructured":"Xu JY, Ma SQ, Pan C et al (2015) A high mean arterial pressure target is associated with improved microcirculation in septic shock patients with previous hypertension: a prospective open label study. Crit Care. https:\/\/doi.org\/10.1186\/s13054-015-0866-0","journal-title":"Crit Care"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03568-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03568-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03568-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T03:30:34Z","timestamp":1694662234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03568-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":64,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["3568"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03568-3","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}